Definitive Healthcare (NASDAQ:DH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Definitive Healthcare (NASDAQ:DH) released its earnings results on Thursday. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02, FiscalAI reports. Definitive Healthcare had a negative net margin of 69.18% and a positive return on equity of 4.07%. The business had revenue of $54.65 million during the quarter, compared to analysts’ expectations of $54.58 million.

Definitive Healthcare Stock Up 1.8%

Shares of DH traded up $0.02 during mid-day trading on Friday, reaching $1.15. The company’s stock had a trading volume of 324,402 shares, compared to its average volume of 394,086. Definitive Healthcare has a 12-month low of $0.61 and a 12-month high of $3.00. The stock has a market cap of $122.76 million, a PE ratio of -0.77, a price-to-earnings-growth ratio of 14.19 and a beta of 1.40. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.86 and a quick ratio of 1.86. The company’s 50 day moving average is $1.02 and its 200 day moving average is $1.06.

Analyst Upgrades and Downgrades

Several research firms have weighed in on DH. Morgan Stanley decreased their target price on shares of Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating on the stock in a report on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $1.00 price target on shares of Definitive Healthcare in a research note on Wednesday, August 12th. BTIG Research restated a “neutral” rating on shares of Definitive Healthcare in a report on Friday, September 4th. Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Sunday, September 13th. Finally, Weiss Ratings upgraded Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday. Six investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $1.47.

About Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.